US$ 26.56
glp-1 drug market competition 2025 Receptor Agonist Size & Analysis, 2026-2033 GLP-1 Trends: Costs & Coverage
Description
I welcome all types of feedback and constructive discussion to improve my content

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes

GLP-1 Receptor Agonists: A Possible Solution for When Diet and Exercise Are Just Not Enough

They are also known as GLP-1 analogues or incretin mimetics

Each sample was run in duplicate
J Biol Chem (2004) 279(50):5233845
